01:29 AM EDT, 07/24/2026 (MT Newswires) -- BB Biotech (BION.SW) said Friday it returned to profit in the first half, while operating income soared year over year. Profit for the six months ended June 30 was 429.8 million francs, compared with a loss of 341.2 million francs a year ago. EPS totaled 7.79 francs, compared with a loss per share of 6.24 francs. The Swiss biotechnology investor's operating income was 451.5 million francs, compared with 1.8 million francs earlier.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.